Pharmacokinetic-stereoselective differentiation of some isomeric analogues of ifosfamide

Polish Journal of Pharmacology

Volumn 49, Issue 6, 1997, Pages 463-469

  Sloderbach, Anna ^a   Hładoń, Bogusław ^a   Sochacki, Marek ^b   Kinas, Ryszard ^b   Kuśnierczyk, Halina ^c   Laskowska, Halina ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b CENTRE OF MOLECULAR AND MACROMOLECULAR STUDIES   (Poland)

^c INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Bioavailability; Isofosfamide bromine analogues; Pharamcokinetics

Indexed keywords

IFOSFAMIDE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG HALF LIFE; ENANTIOMER; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; RAT; STEREOCHEMISTRY; STEREOISOMERISM;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; BIOLOGICAL AVAILABILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; IFOSFAMIDE; INJECTIONS, INTRAPERITONEAL; MALE; RATS; RATS, WISTAR; STEREOISOMERISM;

EID: 2642672003     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Antman K. H., Montella D., Rosenbaum C.: Phase II trial of ifosfamide with mesna in previously treated metastatic sarcoma. Cancer Treatment Rep., 1985, 69, 499-504.
2. Bremmer D. N., Cormick Mc. J., Thomson J. W.: Clinical trial of isophosphamide (NSC-109724) - results and side effects. Cancer Chemother. Rep., 1974, 58, 889-893.
3. Glazman-Kuśnierczyk H., Matuszyk J., Radzikowski C.: Antitumor activity evaluation of bromine-substituted analogues of ifosfamide. I. Stereodifferentiation of biological effects and selection of the most potent compounds. Immunopharmacol. Immunotoxicol., 1992, 14, 883-911.
4. Graham M. J., Shaw J. C., Souhami R. L., Sidan B., Harper P. G., Maclean A. E.: Decreased plasma half-life of cyclophosphamide during repeated high dose administration. Cancer Chemother. Pharmacol., 1983, 10, 192-193.
5. Hładoń B., Sloderbach A., Laskowska H.: Enantioselective cytotoxic activity of bromine-substituted analogues of ifosfamide. A microsomal implication. Pol. J. Pharmacol., 1997, 49, 127-136.
6. Jardine J., Fenselau C., Appler M., Kan M. N., Brundrett R. B., Colvin N.: Quantitation by gas chromatography - chemical ionization - mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy. Cancer Res., 1978, 38, 408-415.
7. Kinas R., Pankiewicz K., Stec W. J.: The synthesis of enantiomeric cyclophosphamides. Bull. Pol. Acad. Sci., 1975, 23, 981-984.
8. Kinas R. W., Pankiewicz K., Stec W. J., Farmer P. B., Foster A. B., Jarman M.: The synthesis of the optical isomers of 2-(2-chloroethylamino)-3-(2-chloroethyl)-tetrahydro-2H-1,3,2-oxazaphosphorine-2- oxide (ifosfamide). Bull. Pol. Acad. Sci., 1978, 26, 39-42.
9. Klein H. O., Wickramanayake P. D., Christian E., Coerper C.: Therapeutic effects of single-push or fractionated injections or continuous infusion of oxazophosphorines (cyclophosphamide, ifosfamide, Asta Z7557). Cancer, 1984, 54, Suppl. 6, 1193-1203.
10. Klein H. O., Wickramanayake D. P., Coerper C., Christian E., Pohl J., Brock N.: High-dose ifosfamide and mesna as continuous infusion over five days - a phase I/II trial. Cancer Treatment Rev., 1983, 10, Suppl. A, 167-173.
11. Kuśnierczyk H., Radzikowski C., Paprocka M., Budzyński W., Rak J., Kinas R. W., Misiura K., Stec W.: Antitumor activity of optical isomers of cyclophosphamide, ifosfamide and trofosfamide as compared to clinically used racemates. J. Immunopharmacol., 1986, 8, 455-480.
12. Lind M. J., Margison J. M., Cerny T., Tchatcher N., Wilkinson P. M.: Comparative pharmacokinetics and alkylating activity of fractionated intravenous and oral ifosfamide in patients with bronchogenic carcinoma. Cancer Res., 1989, 49, 753-757.
13. Meanwell C. A., Mould J. J., Blackedge G.: Phase II study of ifosfamide in cervical cancer. Cancer Treatment Rep., 1986, 70, 727-730.
14. Misiura K., Kinas R. W., Stec W. J., Kuśnierczyk H., Radzikowski C., Sonoda A.: Synthesis and antitumor activity of analogues of ifosfamide modified in the N-(2-chloroethyl) group. J. Med. Chem., 1988, 31, 226-230.
15. Morgan L. R., Harrison E. F., Hawke J. E., Hunter H. L., Costanzi J. J., Plotkin D., Tucker W. G., Worall P. H.: Toxicity of single vs fractionated - dose ifosfamide in non small cell lung cancer. A multicenter study. Semin. Oncol., 1982, 9, 66-70.
16. Pankiewicz K., Kinas R., Stec W. J., Foster A. B., Jarman M., van Maanen J. M. S.: Synthesis and absolute configuration assignments of enantiomeric forms of ifosphamide, sulfosphamide and trofosphamide. J. Amer. Chem. Soc., 1979, 101, 7712-7718.
17. Pantarotto C., Martini A., Belvedere G., Donelli M. G., Frigerio A.: Studies on disposition of cyclophosphamide (NCS - 26271) in tumor bearing mice by means of gas chromatography - chemical ionization - mass fragmentography. Cancer Treatment Rep., 1976, 60, 493-500.
18. Pearson E. S., Hartley H. G.: Biometrie Tables for Statisticians. Cambridge Press, London, 1962, 165.
19. Pratt C. B., Horowitz M. E., Meyer W. H.: Phase II trial of ifosfamide in children with malignant solid tumors. Cancer Treatment Rep., 1987, 71, 131-135.
20. Sloderbach A.: Cytostatic activity and bioavailability of stereoisomeric analogues of ifosfamide. Doctoral Thesis, University of Medical Sciences, Poznań, 1993.
21. Sloderbach A., Hładoń B., Laskowska H.: Enantioselective bioequivalence of ifosfamide stereoisomeric analogues. First European Congress of Pharmacology, Milan 1995, Pharmacol. Res., 1995, 31 Suppl., 43.
22. Sloderbach A., Hładoń. B., Sochacki. M.: The application of mass fragmentography for pharmacokinetic analysis of ifosfamide derivatives. In: Abstracts of XXIII Symposium of the Polish Chemical Society, Białystok, 1992, 25.
23. Wagner T., Drings P.: Pharmacokinetics and bioavailability of oral ifosfamide. Contr. Oncol., 1987, 26, 53-59.
24. Wagner T., Fenneberg K.: Pharmacokinetics and bioavailability of cyclophosphamide from oral formulations. Arzneim.-Forsch. - Drug Res., 1986, 34, 313-316.
25. Weber E.: Grundriss der Biologischen Statistik. VEB G. Fischer Verlag, Jena, 1957, 45.